Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Epidural Abscess Treatment Market from 2024 to 2025?
The market for the treatment of epidural abscess has seen significant expansion in the past few years. The market is projected to increase from $41.11 billion in 2024 to $44.01 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The previous growth can be linked to the rising incidence of epidural abscesses, elevated health care spending, heightened disease awareness, and an escalating demand for combination treatments.
What Is the Projected Market Size of the Epidural Abscess Treatment Market?
The market for treating epidural abscess is projected to experience robust growth in the coming years, reaching a value of $56.78 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 6.6%. The expected upswing during this forecast period can be attributed to an increase in the aging population, government interventions, investments in research and development related to epidural abscess, and a rise in the occurrence of spinal epidural abscesses. Key trends that will shape the market during this forecast period include advancements in healthcare technology, the application of digital health technologies in managing epidural abscess, the use of artificial intelligence in diagnosing and treating epidural abscess, and the availability of cost-effective treatments for epidural abscess.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12904&type=smp
Who are the Major Competitors in the Epidural Abscess Treatment Market Outlook?
Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, UCB Pharma, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Ferring B.V., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals.
What Is Fueling Growth in the Epidural Abscess Treatment Market?
The growth of the epidural abscess treatment market is predicted to be fueled by the rising occurrence of neurological disorders. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves. Such disorders often lead to ailments like acute spinal cord injury, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), and others. Treatment of epidural abscess, often used for neurological disorders, involves quickly draining the abscess surgically and administering antibiotics to avert spinal cord and nerve compression, thereby alleviating pressure on the spinal cord and nerves. For example, in March 2022, the Alzheimer’s Association, a US-based nonprofit organization, estimated that an approximate 6.7 million Americans aged 65 and older will be living with Alzheimer’s in 2023, a number anticipated to rise to 12.7 million by 2050. Consequently, the increasing prevalence of neurological disorders is anticipated to bolster the epidural abscess treatment market. The growth of the epidural abscess treatment market is also expected to be propelled by the rising usage of intravenous drugs. Intravenous drug usage involves injecting drugs directly into the bloodstream using a hypodermic needle and syringe. This practice can cause epidural abscesses if contaminated injection tools or drugs introduce bacteria or pathogens into the bloodstream, thereby calling for specialized treatments, care, and prevention programs. For example, in July 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that between 2022-2023, about 1.4% of individuals aged 14 and above admitted to having injected a drug at least once in their lifetime, and 0.2% reported having injected a drug within the past year. As such, the escalating usage of intravenous drugs is set to enhance the epidural abscess treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12904&type=smp
Which Epidural Abscess Treatment Market Segments Are Growing the Fastest?
The epidural abscess treatment market covered in this report is segmented –
1) By Type: Intracranial, Intraspinal
2) By Treatment: Antifungal, Antibiotics, Surgery
3) By End-User: Hospital, Pharmacy, Specialty Clinics, Other End-Users
Subsegments:
1) By Intracranial: Brain Abscess, Subdural Abscess, Epidural Abscess in the Cranium
2) By Intraspinal: Cervical Epidural Abscess, Thoracic Epidural Abscess, Lumbar Epidural Abscess, Sacral Epidural Abscess
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report
Which Countries Are Leading the Epidural Abscess Treatment Market?
North America was the largest region in the epidural abscess treatment market in 2024. The regions covered in epidural abscess treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12904
This Report Delivers Insight On:
1. How big is the epidural abscess treatment market, and how is it changing globally?
2. Who are the major companies in the epidural abscess treatment market, and how are they performing?
3. What are the key opportunities and risks in the epidural abscess treatment market right now?
4. Which products or customer segments are growing the most in the epidural abscess treatment market?
5. What factors are helping or slowing down the growth of the epidural abscess treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
